The role of MICOS in modulating mitochondrial dynamics and structural changes in vulnerable regions of Alzheimer’s Disease

preprint OA: closed CC-BY-NC-ND-4.0
📄 Open PDF Full text JSON View at publisher
Full text 2,505 characters · extracted from oa-doi-fallback · click to expand
The role of MICOS in modulating mitochondrial dynamics and structural changes in vulnerable regions of Alzheimer’s Disease Abstract Mitochondrial contact site and cristae organizing system (MICOS) complexes are critical for maintaining the mitochondrial architecture, cristae integrity, and organelle communication in neurons. MICOS disruption has been implicated in neurodegenerative disorders, including Alzheimer’s disease (AD), yet the spatiotemporal dynamics of MICOS-associated neuronal alterations during aging remain unclear. Using three-dimensional reconstructions of hypothalamic and cortical neurons, we observed age-dependent fragmentation of mitochondrial cristae, reduced intermitochondrial connectivity, and compartment-specific changes in mitochondrial size and morphology. Notably, these structural deficits were most pronounced in neurons vulnerable to AD-related pathology, suggesting a mechanistic link between MICOS disruption and the early mitochondrial dysfunction observed in patients with AD. Our findings indicate that the loss of MICOS integrity is a progressive feature of neuronal aging, contributing to impaired bioenergetics and reduced resilience to metabolic stress and potentially facilitating neurodegenerative processes. MICOS disruption reduced neuronal firing and synaptic responsiveness, with miclxin treatment decreasing mitochondrial connectivity and inducing cristae disorganization. These changes link MICOS structural deficits directly to impaired neuronal excitability, highlighting vulnerability to AD-related neurodegeneration. These results underscore the importance of MICOS as a critical determinant of neuronal mitochondrial health and as a potential target for interventions aimed at mitigating AD-related mitochondrial dysfunction. Competing Interest Statement The authors have declared no competing interest. Footnotes Funder Information Declared Subject Area - Biochemistry (17705) - Bioengineering (13899) - Bioinformatics (41968) - Biophysics (21460) - Cancer Biology (18603) - Cell Biology (25526) - Clinical Trials (138) - Developmental Biology (13385) - Ecology (19910) - Epidemiology (2067) - Evolutionary Biology (24328) - Genetics (15614) - Genomics (22513) - Immunology (17741) - Microbiology (40423) - Molecular Biology (17193) - Neuroscience (88646) - Paleontology (667) - Pathology (2835) - Pharmacology and Toxicology (4827) - Physiology (7647) - Plant Biology (15160) - Synthetic Biology (4302) - Systems Biology (9825) - Zoology (2271)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-24T02:00:01.246996+00:00
License: CC-BY-NC-ND-4.0